Advertisement

No bias score yet for this article.

Uses 4 AI models - Takes ~10 seconds

CNBC

India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top

EconomyDaily Composite

Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.

C

Source

CNBC

Read full article at CNBC

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement